• Return to Headlines

Watch for Continued Gains in Shares of Integra Lifescie (IART)

By Shiri Gupta

Integra Lifescie (NASDAQ:IART) traded today at a new 52-week high of $56.95. This new high was reached on below average trading volume as 84,000 shares traded hands, while the average 30-day volume is approximately 290,000 shares.

Integra Lifescie (NASDAQ:IART) is currently priced 1.7% above its average consensus analyst price target of $56.00. The stock should discover initial support at its 50-day moving average (MA) of $40.22 and subsequent support at its 200-day MA of $38.89.

Integra LifeSciences Holdings Corp develops, manufactures, and markets medical devices, implants, and biomaterials. The Company's products are primarily used in the treatment of burns and skin defects, spinal and cranial disorders, orthopedics, and other surgical applications.

In the past 52 weeks, Integra Lifescie share prices have been bracketed by a low of $37.38 and a high of $56.95 and are now at $56.95, 52% above that low price. In the last five trading sessions, the 50-day moving average (MA) has climbed 0.3% while the 200-day MA has risen 0.3%.

SmarTrend recommended that subscribers consider buying shares of Integra Lifescie on February 23rd, 2018 as our proprietary SmarTrend analytics indicated a new Uptrend was in progress when shares hit $53.58. Since that recommendation, shares of Integra Lifescie have risen 4.9%. We continue to monitor IART for any potential shift so investors can protect gains and will alert SmarTrend subscribers immediately.

Keywords: 52 week high/lows integra lifescie

Ticker(s): IART